Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of IXIARO in Pediatric Population
NCT01041573Phase 3Completed
- Sponsor
- Valneva
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Valneva. Started Mar 2010; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01041573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041573.